Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRELID1 pseudogene 2 (PRELID1P2) is a processed pseudogene related to the PRELID1 gene, which encodes a protein involved in mitochondrial lipid transfer and cell death regulation. As a pseudogene, PRELID1P2 does not code for a functional protein and is not implicated as a therapeutic target, receptor, enzyme, transporter, or transcription factor. It is primarily considered a genomic remnant of gene duplication or retrotransposition events and is typically not transcribed into a functional product. There are no established roles for PRELID1P2 in disease processes, drug mechanisms, or as a biomarker. This query appears to be based on a pseudogene, not a canonical protein or therapeutic target. Pseudogenes such as PRELID1P2 generally "provide snapshots of ancient genes" and are not considered functional molecular targets. There is no evidence that PRELID1P2 itself encodes a protein, has biological function, interacting drugs, or relevance in disease or therapy. If the intent was to refer to PRELID1 (PRELI Domain Containing 1), which is a mitochondrial lipid transfer protein and has potential therapeutic implications, clarification would be needed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRELID1 pseudogene 2 (PRELID1P2).